Vortex Biosciences

Vortex Biosciences develops liquid biopsy technology for isolating circulating tumour cells from whole blood.

Its automated, non-contact approach is designed to recover intact, viable cells that can be studied after collection. Preserving cell viability is important for molecular and functional analysis, rather than simply counting cells in a sample.

The platform supports cancer research and has potential applications in disease monitoring and precision oncology.